TP方案治疗晚期肺癌的临床疗效观察

The TP plan treatment later period lung cancer clinical curative effect observes

目的：探讨的TP方案和CAP方案对初治的晚期非小细胞肺癌（NSCLC）的疗效和不良反应.方法：44例晚期NSCLC患者随机分成TP组和CAP组,较两组不同化疗方案的近期疗效和不良反应.结果：治疗组总有效率和1年生存率明显优于对照组（P〈0.05）.不良反应方面,两组以骨髓抑制和消化道症状为主,两组患者的化疗副反应均在可耐受的范围内,差异无统计学意义（P〉0.05）.结论：TP方案治疗晚期肺癌的近远期疗效好,且化疗的不良反应能耐受,临床上可以根据患者的具体情况制定适合其的治疗方案.

Objective： Discusses the TP plan and the CAP plan to the later period noncellule lung cancer （NSCLC） curative effect which initially governs and responded not good. Methods：44 example later period NSCLC patient divides into the TP group and the CAP group stochastically, two group of different chemotherapy plan short-- term curative effect and responded not good. Results. Treats the group total effectiveness and 1 year survival rate surpasses the control group obviously （P〈0. 05）. Responds the aspect not good, two groups by the marrow suppression and the digestive tract symptom primarily,two group of patient＇s chemotherapy side reactions in the scope which may endure,difference non--statistics significance （P〉0. 05）. Conclusion. The TP plan treatment later period lung cancer near forward curative effect is good, also the chemotherapy not good reaction energy tolerance, on clinical may suit its treatment plan according to patient＇s special details formulation.